Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex

[1]  M. Mi,et al.  Segregation analysis. , 2019, American journal of human genetics.

[2]  H. Gurling,et al.  Gene expression in schizophrenia. , 2001, The American journal of psychiatry.

[3]  David A Lewis,et al.  Catching Up on Schizophrenia Natural History and Neurobiology , 2000, Neuron.

[4]  L. Glantz,et al.  Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia , 2000, Biological Psychiatry.

[5]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[6]  David A. Lewis,et al.  Is There a Neuropathology of Schizophrenia? Recent Findings Converge on Altered Thalamic-Prefrontal Cortical Connectivity , 2000 .

[7]  A. Bellack,et al.  Sex differences in illness presentation, course, and level of functioning in substance-abusing schizophrenia patients , 2000, Schizophrenia Research.

[8]  Alcino J. Silva,et al.  Deficits in memory and motor performance in synaptotagmin IV mutant mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H Rusinek,et al.  Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. , 2000, Archives of general psychiatry.

[10]  P. Goldman-Rakic,et al.  Inactivation of parietal and prefrontal cortex reveals interdependence of neural activity during memory-guided saccades. , 2000, Journal of neurophysiology.

[11]  G. Pearlson,et al.  Sex differences in inferior parietal lobule volume in schizophrenia. , 2000, The American journal of psychiatry.

[12]  T. Shors,et al.  Postnatal decrease in transforming growth factor α is associated with enlarged ventricles, deficient amygdaloid vasculature and performance deficits , 2000, Neuroscience.

[13]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[14]  A. Pulver.  Search for schizophrenia susceptibility genes , 2000, Biological Psychiatry.

[15]  M. Tsuang.  Schizophrenia: genes and environment , 2000, Biological Psychiatry.

[16]  S. Hyman.  The NIMH perspective: next steps in schizophrenia research , 2000, Biological Psychiatry.

[17]  P. Greengard,et al.  Characterization of Transcripts from the Synapsin III Gene Locus , 1999, Journal of neurochemistry.

[18]  T. Südhof,et al.  Analysis of SCAMP1 Function in Secretory Vesicle Exocytosis by Means of Gene Targeting in Mice* , 1999, The Journal of Biological Chemistry.

[19]  Kaj Blennow,et al.  The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains , 1999, Schizophrenia Research.

[20]  J. Pierri,et al.  Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. , 1999, The American journal of psychiatry.

[21]  T. Südhof,et al.  Essential Roles in Synaptic Plasticity for Synaptogyrin I and Synaptophysin I , 1999, Neuron.

[22]  K. Jellinger,et al.  The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.

[23]  Ellen J. Hess,et al.  Tottering Mouse Motor Dysfunction Is Abolished on the Purkinje Cell Degeneration (pcd) Mutant Background , 1999, Experimental Neurology.

[24]  M. Owen,et al.  High rates of schizophrenia in adults with velo-cardio-facial syndrome (VCFS) , 1999, Schizophrenia Research.

[25]  D K Ingram,et al.  What counts in brain aging? Design-based stereological analysis of cell number. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[26]  A. Sampson,et al.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. , 1999, The American journal of psychiatry.

[27]  J. Trent,et al.  Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays , 1999 .

[28]  B. Ross,et al.  Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia , 1999, Biological Psychiatry.

[29]  P. Goldman-Rakic,et al.  Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure , 1999, Biological Psychiatry.

[30]  Carol A. Tamminga,et al.  Schizophrenia: new phenes and new genes. , 1999 .

[31]  N. Makris,et al.  Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. , 1999, Archives of general psychiatry.

[32]  S. Bajjalieh.  Synaptic vesicle docking and fusion , 1999, Current Opinion in Neurobiology.

[33]  R. McCarley,et al.  MRI anatomy of schizophrenia , 1999, Biological Psychiatry.

[34]  G. Rogers,et al.  Synergistic interactions between ampakines and antipsychotic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.

[35]  P. Goldman-Rakic,et al.  The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.

[36]  L. Pallanck,et al.  NSF Function in Neurotransmitter Release Involves Rearrangement of the SNARE Complex Downstream of Synaptic Vesicle Docking , 1998, The Journal of Neuroscience.

[37]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Paul J. Harrison,et al.  Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia , 1998, The Lancet.

[39]  K. Hashimoto,et al.  Effect of chronic haloperidol treatment on synaptic protein mRNAs in the rat brain. , 1998, Brain research. Molecular brain research.

[40]  S. Hirsch,et al.  Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[41]  R. Belmaker,et al.  Inositol levels are decreased in postmortem brain of schizophrenic patients , 1998, Biological Psychiatry.

[42]  C. Inglehearn,et al.  Molecular genetics of human retinal dystrophies , 1998, Eye.

[43]  T. Woo,et al.  A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Goldman-Rakic,et al.  Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three‐dimensional, stereologic counting method , 1998, The Journal of comparative neurology.

[45]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[46]  S. Moss,et al.  Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment. , 1998, Brain research. Molecular brain research.

[47]  C. Karson,et al.  86 Reduced levels of synaptic proteins in the prefrontal cortex in schizophrenia , 1997, Schizophrenia Research.

[48]  K. Davis,et al.  Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. , 1997, Archives of general psychiatry.

[49]  M. Linial.  SNARE Proteins‐Why So Many, Why So Few? , 1997, Journal of neurochemistry.

[50]  M. Karayiorgou,et al.  A Turning Point in Schizophrenia Genetics , 1997, Neuron.

[51]  P. Huttenlocher,et al.  Regional differences in synaptogenesis in human cerebral cortex , 1997, The Journal of comparative neurology.

[52]  L. Glantz,et al.  Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.

[53]  B. Sokolov,et al.  Age‐related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics , 1997, Journal of neuroscience research.

[54]  Paul J. Harrison,et al.  Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex , 1997, Schizophrenia Research.

[55]  B. Lipska,et al.  Behavioral changes in rats with early ventral hippocampal damage vary with age at damage. , 1997, Brain research. Developmental brain research.

[56]  Mestman Jh.  Perinatal Thyroid Dysfunction: Prenatal Diagnosis and Treatment. , 1997 .

[57]  T. Südhof,et al.  The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion , 1997, Nature.

[58]  N. Andreasen,et al.  Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients , 1997, The Lancet.

[59]  Z. Vogel,et al.  Differential distribution of synapsin IIa and IIb mRNAs in various brain structures and the effect of chronic morphine administration on the regional expression of these isoforms. , 1997, Brain research. Molecular brain research.

[60]  S. M. Sumi,et al.  Chromosome 17 and hereditary dementia , 1997, Neurology.

[61]  Paul J. Harrison,et al.  Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia , 1997, Biological Psychiatry.

[62]  N. Perrone-Bizzozero,et al.  Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[63]  N C Andreasen,et al.  Pieces of the Schizophrenia Puzzle Fall into Place , 1996, Neuron.

[64]  S. Potkin,et al.  Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  S. Akbarian,et al.  Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia , 1995, Brain Research.

[66]  S. Akbarian,et al.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. , 1995, Cerebral cortex.

[67]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[68]  S. Watson,et al.  Neocortical Abnormalities in Schizophrenia , 1995 .

[69]  D. Weinberger,et al.  From neuropathology to neurodevelopment , 1995, The Lancet.

[70]  J. S. Lund,et al.  Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex , 1995, Neuroscience.

[71]  Thomas C. Südhof,et al.  The synaptic vesicle cycle: a cascade of protein–protein interactions , 1995, Nature.

[72]  T. Südhof,et al.  Essential functions of synapsins I and II in synaptic vesicle regulation , 1995, Nature.

[73]  E. G. Jones,et al.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.

[74]  Paul J. Harrison,et al.  Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. , 1995, Brain research. Molecular brain research.

[75]  B. Pakkenberg,et al.  Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors , 1993, Biological Psychiatry.

[76]  R. Freedman,et al.  Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics , 1993, Biological Psychiatry.

[77]  Paul J. Harrison,et al.  Pre‐and Postmortem Influences on Brain RNA , 1993, Journal of neurochemistry.

[78]  R. Melloni,et al.  Synapsin I Gene expression in the adult rat brain with comparative analysis of mRNA and protein in the hippocampus , 1993, The Journal of comparative neurology.

[79]  J. Collinge,et al.  Decreased Hippocampal Expression of a Glutamate Receptor Gene in Schizophrenia , 1991, British Journal of Psychiatry.

[80]  Paul J. Harrison,et al.  Decreased hippocampal expression of a glutamate receptor gene in schizophrenia , 1991, The Lancet.

[81]  M. Casanova,et al.  Is there a neuropathology of schizophrenia? , 1988, Biological Psychiatry.

[82]  B. Jones,et al.  Hypofrontality in Schizophrenia , 1988, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[83]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[84]  N. Risch,et al.  Segregation analysis of schizophrenia and related disorders. , 1984, American journal of human genetics.

[85]  P. Huttenlocher.  Synaptic density in human frontal cortex - developmental changes and effects of aging. , 1979, Brain research.

[86]  P. Huttenlocher,et al.  Synaptic density in human frontal cortex — Developmental changes and effects of aging , 1979, Brain Research.

[87]  J. Stamm,et al.  Electrical stimulation of monkeys' prefrontal cortex during delayed-response performance. , 1969, Journal of comparative and physiological psychology.

[88]  Paul J. Harrison.  The neuropathology of schizophrenia , 2008 .

[89]  C. Nelson,et al.  Handbook of Developmental Cognitive Neuroscience , 2001 .

[90]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[91]  J A Frank,et al.  Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. , 2000, The American journal of psychiatry.

[92]  S. Hyman,et al.  The genetics of mental illness: implications for practice. , 2000, Bulletin of the World Health Organization.

[93]  T. Südhof,et al.  Membrane fusion and exocytosis. , 1999, Annual review of biochemistry.

[94]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[95]  D. Botstein,et al.  Exploring the new world of the genome with DNA microarrays , 1999, Nature Genetics.

[96]  P. D. de Jong,et al.  Retinitis pigmentosa: defined from a molecular point of view. , 1999, Survey of ophthalmology.

[97]  W Q Sturner,et al.  Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’ , 1999, Molecular Psychiatry.

[98]  Arno Villringer,et al.  Effects of repetitive transcranial magnetic stimulation over dorsolateral prefrontal and posterior parietal cortex on memory-guided saccades , 1998, Experimental Brain Research.

[99]  P. Williamson,et al.  An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. , 1996, Schizophrenia bulletin.

[100]  P. Dillon.  Chapter 30 – 31P Nuclear Magnetic Resonance Spectroscopy , 1996 .

[101]  P S Goldman-Rakic,et al.  Synaptogenesis in the prefrontal cortex of rhesus monkeys. , 1994, Cerebral cortex.

[102]  N. Minshew,et al.  31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. , 1993, Schizophrenia bulletin.

[103]  Michael R. Green,et al.  Gene Expression , 1993, Progress in Gene Expression.